-
EP3687513
European procedure
Extract from the Register of European Patents
EP About this file: EP3687513
| EP3687513 - TREATMENT OF FRAGILE X SYNDROME AND AUTISM WITH CANNABIDIOL [Right-click to bookmark this link] | |||
| Former [2020/32] | TREATMENT OF FRAGILE X SYNDROME WITH CANNABIDIOL | ||
| [2021/28] | Status | No opposition filed within time limit Status updated on 21.10.2022 Database last updated on 22.08.2024 | |
| Former | The patent has been granted Status updated on 12.11.2021 | ||
| Former | Grant of patent is intended Status updated on 06.07.2021 | ||
| Former | Request for examination was made Status updated on 03.07.2020 | ||
| Former | The international publication has been made Status updated on 06.04.2019 | ||
| Former | unknown Status updated on 29.10.2018 | Most recent event Tooltip | 21.10.2022 | No opposition filed within time limit | published on 23.11.2022 [2022/47] | Applicant(s) | For all designated states Zynerba Pharmaceuticals, Inc. 80 W. Lancaster Avenue, Suite 300 Devon, PA 19333 / US | [2020/32] | Inventor(s) | 01 /
BONN-MILLER, Marcel 1112 Riverwood Road Lexington, NC 27292 / US | 02 /
TICH, Nancy 318 Summit Avenue St. Paul, MN 55102 / US | 03 /
GUTTERMAN, Donna 10409 Veasey Mill Road Raleigh, NC 27615 / US | 04 /
MESSENHEIMER, John 55 Hermitage Lane Moncure, NC 27599 / US | 05 /
SEBREE, Terri 922 Merion Square Road Gladwyne, PA 19035 / US | [2021/50] |
| Former [2020/32] | 01 /
BONN-MILLER, Marcel 1112 Riverwood Road Lexington, NC 27292 / US | ||
| 02 /
TICH, Nancy 8 Ashland Terrace Chester, NJ 07930 / US | |||
| 03 /
GUTTERMAN, Donna 10409 Veasey Mill Road Raleigh, NC 27615 / US | |||
| 04 /
MESSENHEIMER, John 55 Hermitage Lane Moncure, NC 27599 / US | |||
| 05 /
SEBREE, Terri 922 Merion Square Road Gladwyne, PA 19035 / US | Representative(s) | Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE | [2020/32] | Application number, filing date | 18788905.0 | 27.09.2018 | [2020/32] | WO2018IB57519 | Priority number, date | US201762564834P | 28.09.2017 Original published format: US 201762564834 P | US201862632532P | 20.02.2018 Original published format: US 201862632532 P | [2020/32] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2019064234 | Date: | 04.04.2019 | Language: | EN | [2019/14] | Type: | A1 Application with search report | No.: | EP3687513 | Date: | 05.08.2020 | Language: | EN | The application published by WIPO in one of the EPO official languages on 04.04.2019 takes the place of the publication of the European patent application. | [2020/32] | Type: | B1 Patent specification | No.: | EP3687513 | Date: | 15.12.2021 | Language: | EN | [2021/50] | Search report(s) | International search report - published on: | EP | 04.04.2019 | Classification | IPC: | A61K31/05, A61P25/00 | [2020/32] | CPC: |
A61K31/05 (EP,IL,KR,US);
A61K31/658 (EP,KR);
A61K36/185 (IL,KR,US);
A61K9/0014 (IL,KR,US);
A61K9/06 (IL,KR,US);
A61P25/00 (EP,IL,KR,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2020/32] | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | KH | Not yet paid | MA | Not yet paid | MD | Not yet paid | TN | Not yet paid | Title | German: | BEHANDLUNG VON FRAGILEM-X-SYNDROM UND AUTISMUS MIT CANNABIDIOL | [2021/28] | English: | TREATMENT OF FRAGILE X SYNDROME AND AUTISM WITH CANNABIDIOL | [2021/28] | French: | TRAITEMENT DU SYNDROME DE L'X FRAGILE ET DE L'AUTISME AVEC DU CANNABIDIOL | [2021/28] |
| Former [2020/32] | BEHANDLUNG VON FRAGILEM-X-SYNDROM MIT CANNABIDIOL | ||
| Former [2020/32] | TREATMENT OF FRAGILE X SYNDROME WITH CANNABIDIOL | ||
| Former [2020/32] | TRAITEMENT DU SYNDROME DE L'X FRAGILE AVEC DU CANNABIDIOL | Entry into regional phase | 27.03.2020 | National basic fee paid | 27.03.2020 | Designation fee(s) paid | 27.03.2020 | Examination fee paid | Examination procedure | 27.03.2020 | Examination requested [2020/32] | 27.03.2020 | Date on which the examining division has become responsible | 17.11.2020 | Amendment by applicant (claims and/or description) | 07.07.2021 | Communication of intention to grant the patent | 05.11.2021 | Fee for grant paid | 05.11.2021 | Fee for publishing/printing paid | 05.11.2021 | Receipt of the translation of the claim(s) | Divisional application(s) | EP21206188.1 / EP3967301 | EP24174294.9 | Opposition(s) | 16.09.2022 | No opposition filed within time limit [2022/47] | Fees paid | Renewal fee | 14.09.2020 | Renewal fee patent year 03 | 15.09.2021 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [AD]WO2010127033 (ALLTRANZ INC [US], et al); | by applicant | WO2010127033 |